United States: Sir Adrian Hill, the leader of the malaria vaccine development team at the University of Oxford, believes this new vaccine can save up to hundreds of thousands of lives over the coming decade.
Hill, a professor of vaccinology, hopes that this vaccine, which is the second of its kind, will be a major step toward fully barring malaria.
First Malaria Vaccine to Meet WHO Efficacy Target
This particular vaccine which has been hailed as a scientific advance is the first malaria vaccine to meet the World Health Organisation target of 75 percent of the efficacy at precluding the complaint.
The first doses were rolled out in the Ivory Coast on Monday and were developed under Sir Adrian at the university’s Jenner Institute.
A conversation with BBC Radio 4 Today programme, Sir Adrian said: “I think during this decade, we can knock half a million deaths a year right down to maybe 200,000 if things go well and then, ultimately, probably next decade will be a really serious attempt at eliminating and eradicating malaria.”
Vaccine Described as “The Best Vaccine We Now Have”
As reported in Independent,
Named R21/Matrix-M, Sir Adrian described the vaccine as “the best vaccine we now have”.
He said: “It’s less expensive, it’s more available, and it works better. This is a vaccine that was designed and developed in 2012 and has been progressing since then.”
He said the vaccine is at a price point “where it’s realistic to roll this out in many tens of millions of doses from now on”.
This particular vaccine is given to the children of at least five, six and almost seven months of age and four weeks apart which is followed by a booster after a year.
It primes the blood with antibodies that target the malaria protein, known as circumsporozoite protein (CSP).
Past Successes and Future Goals
Vaccine works by aiming at malaria pathogens and in the first two-hour window when it enters the body, and it also includes the body to produce antibodies also to neutralize the parasite by creating a very strong immune response. Though in 2020, the Jenner Institute created the Oxford AstraZeneca Covid-19 vaccine.
About the Author
